Compared with STAS , no difference was noted in PSA progression with ITAS or STAS plus zoledronic acid ; however , ITAS plus zoledronic acid reduced PSA progression ( sub-hazard ratio [ SHR ] 071 , 95 % CI 053-095 ; p = 0021 ) .